Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: Relationship with cell cycle regulators
暂无分享,去创建一个
R. Ralhan | M. Mathur | Anupam Kumar | N. Shukla | J. Kaur | S. Bahadur | N. Chakravarti | Chavvi Sharma | Suryanaryana VS Deo
[1] R. Ralhan,et al. Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. , 2004, Journal of experimental therapeutics & oncology.
[2] R. Ralhan,et al. Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. , 2003, Oral oncology.
[3] E. Parkinson,et al. Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-β: but p53 mutations are not necessarily required , 2003, Oncogene.
[4] A. Tarrade,et al. The AF-1 and AF-2 Domains of RARγ2 and RXRα Cooperate for Triggering the Transactivation and the Degradation of RARγ2/RXRα Heterodimers* , 2003, Journal of Biological Chemistry.
[5] H. Schliephake,et al. Prognostic relevance of molecular markers of oral cancer--a review. , 2003, International journal of oral and maxillofacial surgery.
[6] R. Ralhan,et al. Retinoic acid receptor‐alpha as a prognostic indicator in oral squamous cell carcinoma , 2003, International journal of cancer.
[7] Daniel G. Tenen,et al. Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.
[8] E. Parkinson,et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. , 2002, Cancer research.
[9] M. Hung,et al. Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells , 2002, Oncogene.
[10] G. Snow,et al. Nonmalignant Oral Keratinocytes from Patients with Head and Neck Squamous Cell Carcinoma Show Enhanced Metabolism of Retinoic Acid , 2002, Oncology.
[11] R. Ralhan,et al. Prognostic factors in betel and tobacco related oral cancer. , 2002, Oral oncology.
[12] M. Dawson,et al. Nicotine modulates the effects of retinoids on growth inhibition and RARβ expression in lung cancer cells , 2002, International journal of cancer.
[13] Wei Zhang,et al. The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. , 2002, World journal of gastroenterology.
[14] Rosalie C Sears,et al. Signaling Networks That Link Cell Proliferation and Cell Fate* , 2002, The Journal of Biological Chemistry.
[15] Shu-Chun Lin,et al. The retinoic acid receptor-β (RAR-β) mRNA expression in the oral squamous cell carcinoma associated with betel quid use , 2002 .
[16] S. Groshen,et al. The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] Lucia Altucci,et al. The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.
[18] R. Lotan,et al. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RARβ and on retinoid resistance in human squamous carcinoma cells , 2001, Oncogene.
[19] G. Snow,et al. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines , 2001, International journal of cancer.
[20] D. Alberts,et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. , 2001, Cancer research.
[21] Takemi Tanaka,et al. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors α and γ through proteasomes in mcf-7 human breast cancer cells , 2001 .
[22] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[23] E. Dmitrovsky,et al. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function , 2001, Oncogene.
[24] S. Lippman,et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. , 2001, Journal of the National Cancer Institute.
[25] G. Snow,et al. Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] S. Groshen,et al. Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence , 2001 .
[27] C. Berg,et al. Secondary chemoprevention of upper aerodigestive tract tumors. , 2001, Seminars in oncology.
[28] R. Lotan,et al. Overexpression of Retinoic Acid Receptor β Induces Growth Arrest and Apoptosis in Oral Cancer Cell Lines , 2001, Japanese journal of cancer research : Gann.
[29] M. Spitz,et al. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Takashi Suzuki,et al. Retinoic Acid Receptor and Retinoid × Receptor in Ductal Carcinoma in situ and Intraductal Proliferative Lesions of the Human Breast , 2000, Japanese journal of cancer research : Gann.
[31] D. Bok,et al. Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin:retinol acyltransferase in carcinoma lines. , 2000, Carcinogenesis.
[32] S. Lippman,et al. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] R. Ralhan,et al. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer. , 2000, The American journal of pathology.
[34] O. Dalesio,et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. , 2000, Journal of the National Cancer Institute.
[35] B. Min,et al. Retinoic acid extends the in vitro life span of normal human oral keratinocytes by decreasing p16(INK4A) expression and maintaining telomerase activity. , 2000, Biochemical and biophysical research communications.
[36] J. Califano,et al. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] D. Xiao,et al. Orphan Receptor COUP-TF Is Required for Induction of Retinoic Acid Receptor β, Growth Inhibition, and Apoptosis by Retinoic Acid in Cancer Cells , 2000, Molecular and Cellular Biology.
[38] N. Martinet,et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. , 1999, Journal of the National Cancer Institute.
[39] R. Lotan,et al. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. , 1999, Cancer research.
[40] P. Gupta. Gutka: a major new tobacco hazard in India. , 1999, Tobacco Control.
[41] S. Hsu,et al. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. , 1999, Experimental cell research.
[42] R. Ralhan,et al. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications. , 1999, Oral oncology.
[43] R. Ralhan,et al. pRb and p16 protein alterations in human oral tumorigenesis. , 1998, Oral oncology.
[44] J. Mork. Forty years of monitoring head and neck cancer in Norway--no good news. , 1998, Anticancer research.
[45] R. Ralhan,et al. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status. , 1998, Oral oncology.
[46] R. Ralhan,et al. Prognostic significance of p53 protein overexpression in betel‐ and tobacco‐related oral oncogenesis , 1998, International journal of cancer.
[47] S. Chen,et al. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. , 1998, The Journal of clinical investigation.
[48] L. Razanamahefa,et al. Retinoic acid suppresses insulin-induced cell growth and cyclin D1 gene expression in human breast cancer cells. , 1998, International journal of oncology.
[49] A. Børresen-Dale,et al. Interaction between bcl‐2 and p21 (WAF1/CIP1) in breast carcinomas with wild‐type p53 , 1997, International journal of cancer.
[50] D. Soutar,et al. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype. , 1997, Cancer research.
[51] R. Lotan,et al. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. , 1997, Journal of the National Cancer Institute.
[52] S. Piantadosi,et al. Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.
[53] J. Geradts,et al. High frequency of aberrant p16(INK4A) expression in human breast cancer. , 1996, The American journal of pathology.
[54] J S Lee,et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.
[55] R. Ralhan,et al. Overexpression of p53 protein in betel‐ and tobacco‐related human oral dysplasia and squamous‐cell carcinoma in India , 1994, International journal of cancer.
[56] R. Lotan,et al. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. , 1994, Cancer research.
[57] P. Boyle,et al. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem , 1994, Cancer Causes & Control.
[58] S. Lippman,et al. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. , 1994, Journal of the National Cancer Institute.
[59] S. Lippman,et al. Head and Neck Cancer , 1993, Cancer Treatment and Research.
[60] R. Weber,et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. , 1993, The New England journal of medicine.
[61] Rajanna,et al. A population-based case-control investigation on cancers of the oral cavity in Bangalore, India. , 1990, British Journal of Cancer.
[62] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[63] M. Spitz,et al. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. , 1989, International journal of radiation oncology, biology, physics.
[64] P. Rubin,et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. , 1989, International journal of radiation oncology, biology, physics.
[65] P. Boyle,et al. RISING MORTALITY FROM CANCER OF THE TONGUE IN YOUNG SCOTTISH MALES , 1987, The Lancet.
[66] W. Hong,et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.
[67] B. Vikram. Changing patterns of failure in advanced head and neck cancer. , 1984, Archives of otolaryngology.
[68] M. Sporn,et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.
[69] V. Aa,et al. Letter: Nutritional muscular dystrophy and human myocardial infarction. , 1973 .
[70] D. Slaughter,et al. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.
[71] V. Zoumpourlis,et al. Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index , 2004, Virchows Archiv.
[72] A. Tarrade,et al. The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. , 2003, The Journal of biological chemistry.
[73] Shu-Chun Lin,et al. The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use. , 2002, Journal of Oral Pathology & Medicine.
[74] R. Ralhan,et al. Expression of RARα and RARβ in human oral potentially malignant and neoplastic lesions , 2001 .
[75] S. Groshen,et al. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. , 2001, Surgery.
[76] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[77] L. D. De Luca,et al. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. , 2001, Biochemical pharmacology.
[78] R. Oliver,et al. Oral cancer in young adults: report of three cases and review of the literature. , 2000, British dental journal.
[79] E. Nabeyrat,et al. Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21(CIP1) downregulation. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[80] H. de Thé. Altered retinoic acid receptors. , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[81] S. Lippman,et al. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. , 1992, Important advances in oncology.
[82] J. Jacobs,et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. , 1991, International journal of radiation oncology, biology, physics.
[83] S. Taylor. Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.
[84] C. Marth,et al. Vitamin A status and retinoid-binding proteins in carcinomas of the head and neck region. , 1983, Oncology.